Product Information
TADALAFIL 2.5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1164 per EA under NDC 33342026507. Its NADAC has been published 319 times since Jul 15, 2020.
FDA first approved this application on Oct 7, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342026507
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TADALAFILApproval Type
Generic (ANDA)
FDA Application
ANDA207244FDA Approved
10/7/2019
TE Code
AB1
On Market Since
10/8/2019
Pharmacological Classes
Price Statistics
The NADAC for TADALAFIL 2.5 MG TABLET has been published 319 times since Jul 15, 2020, and over the history we have for it it has declined 57.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1164 per EA |
|---|---|
| All-time high | $0.3319 (Aug 12, 2020) |
| All-time low | $0.0828 (Jul 17, 2024) |
| 52-week high | $0.1298 |
| 52-week low | $0.1143 |
| Median price | $0.1620 |
| Average price | $0.1659 |
| Largest weekly change | +53.6% (Aug 21, 2024) |
| Weeks tracked | 319 |
| Tracking since | Jul 15, 2020 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TADALAFIL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 2.5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.1164 per EA (NDC 33342026507), effective Aug 19, 2026.
How has the price of TADALAFIL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TADALAFIL 2.5 MG TABLET has declined 57.0%. It has been tracked across 319 weekly CMS publications since Jul 15, 2020.
What are the highest and lowest recorded NADAC prices for TADALAFIL 2.5 MG TABLET?
Since Jul 15, 2020, the NADAC for TADALAFIL 2.5 MG TABLET has ranged from a low of $0.0828 (Jul 17, 2024) to a high of $0.3319 (Aug 12, 2020), with a median of $0.1620 per EA.
Are there cheaper alternatives to TADALAFIL 2.5 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 2.5 MG TABLET, is $0.1124 per EA — about 3% below TADALAFIL 2.5 MG TABLET.
Who manufactures TADALAFIL 2.5 MG TABLET?
TADALAFIL 2.5 MG TABLET (NDC 33342026507) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.